Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure. [electronic resource]
Producer: 20100507Description: 31-4 p. digitalISSN:- 1532-8414
- Cyclic GMP
- Drug Therapy, Combination
- Heart Failure -- complications
- Humans
- Hypertension, Pulmonary -- complications
- Isosorbide Dinitrate -- therapeutic use
- Male
- Middle Aged
- Nitro Compounds -- therapeutic use
- Nitroglycerin -- therapeutic use
- Phosphodiesterase 5 Inhibitors
- Phosphodiesterase Inhibitors -- therapeutic use
- Piperazines -- therapeutic use
- Pulmonary Artery -- drug effects
- Purines -- therapeutic use
- Sildenafil Citrate
- Sulfones -- therapeutic use
- Vasodilation -- drug effects
- Vasodilator Agents -- therapeutic use
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.